Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05094804
Title A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With a PD-1 Inhibitor
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors OncoResponse, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.